The effect of DPP-4 inhibitors therapy on the left atrial volume index in patients with type 2 diabetes mellitus

被引：0
|
作者：
Papazafiropoulou, A. K. [1 ,2 ]
Trikkalinou, A. [1 ,2 ]
Ganotopoulou, A. [1 ,2 ]
Kasinos, N. [3 ]
Ioannidis, C. [3 ]
Tountas, C. [3 ]
Foussas, S. [3 ]
Melidonis, A. [1 ,2 ]
机构：
[1] Tzaneio Gen Hosp, Dept Internal Med 1, Piraeus, Greece
[2] Tzaneio Gen Hosp, Ctr Diabet, Piraeus, Greece
[3] Tzaneio Gen Hosp, Dept Cardiol, Piraeus, Greece
来源：
ARCHIVES OF HELLENIC MEDICINE | 2016年 / 33卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：708 / +
页数：2
相关论文
共 50 条
  • [41] DPP-4 inhibitors and cardiovascular disease in type 2 diabetes mellitus. Expectations, observations and perspectives
    Bonora, Enzo
    Cigolini, Massimo
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2016, 26 (04) : 273 - 284
  • [42] AN OBSERVATIONAL STUDY ON THE EFFECT OF DPP-4 INHIBITOR THERAPY IN PATIENTS WITH POST TRANSPLANT DIABETES MELLITUS
    Thiruvengadam, Srivathsan
    Bennett, Kirsten
    Chakera, Aron
    TRANSPLANT INTERNATIONAL, 2017, 30 : 509 - 509
  • [43] Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
    Gallwitz, Baptist
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 1 - 9
  • [44] Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes
    Sutton, Jon M.
    Clark, David E.
    Dunsdon, Stephen J.
    Fenton, Garry
    Fillmore, Amanda
    Harris, Neil V.
    Higgs, Chris
    Hurley, Chris A.
    Krintel, Sussie L.
    MacKenzie, Robert E.
    Duttaroy, Alokesh
    Gangl, Eric
    Maniara, Wiesia
    Sedrani, Richard
    Namoto, Kenji
    Ostermann, Nils
    Gerhartz, Bernd
    Sirockin, Finton
    Trappe, Joerg
    Hassiepen, Ulrich
    Baeschlin, Daniel K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (03) : 1464 - 1468
  • [45] Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
    Ahren, Bo
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 31 - 41
  • [46] SEPTAL AND LEFT ATRIAL VOLUME INDEX AS PREDICTORS FOR HFPEF AMONGST TYPE 2 DIABETES MELLITUS PATIENTS
    Radzi, Ahmad Bakhtiar Md
    Kasim, Sazzli Shahlan
    JOURNAL OF HYPERTENSION, 2023, 41 : E198 - E198
  • [47] Effect on DPP-4 Inhibitors on Fat Metabolism in Patients with Diabetes and Obesity
    Ametov, Alexander, Sr.
    Gusenbekova, Dinara, Jr.
    DIABETES, 2019, 68
  • [48] Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
    Sim, A. Young
    Barua, Sumit
    Kim, Jong Youl
    Lee, Yong-ho
    Lee, Jong Eun
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [49] EFFECTS OF SGLT-2 INHIBITORS VERSUS DPP-4 INHIBITORS ON ANEMIA IN PATIENTS WITH TYPE 2 DIABETES
    Yang, Ai-Yu
    Chen, Hung-Chun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1007 - I1008
  • [50] Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
    Abd A. Tahrani
    Milan K. Piya
    Anthony H. Barnett
    Advances in Therapy, 2009, 26 : 249 - 262
12345